With $1.3bn invested in over 200 high-tech start-ups, OurCrowd is now sharpening its focus on medtech. Medtech Insight spoke to founder Jon Medved to find out more.
Listen here.
![[OurCrowd in CrowdFund Insider] Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[OurCrowd in CrowdFund Insider] Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date
February 13, 2020
[OurCrowd in Crowdfund Insider] OurCrowd Hosts Event with Emirates Angels Investors Association as Diplomatic Thaw Opens Up Opportunity
October 13, 2020
